Search for: "Sandoz GmbH"
Results 1 - 20
of 68
Sort by Relevance
|
Sort by Date
23 Sep 2022, 9:39 am
CALVET NV, HEMMAR PVC NV and URBAN GMBH & CO MASCHINENBAU KGAnother unmissable decision for this annual case law review is the judgment rendered by the Dutch-speaking Enterprise Court of Brussels on double patenting. [read post]
12 Aug 2022, 6:48 pm
GmbH v. [read post]
5 Oct 2020, 2:00 am
Standard Verlags GmbH, the Judge started by recalling that the "close connection" criteria requires the same situation of fact and law. [read post]
7 Jul 2020, 9:15 am
Sandoz, Inc., Sandoz International GMBH, Sandoz GMBH, holding that Sandoz failed to prove that the asserted claims were invalid for obviousness-type double patenting (ODP), failure to meet the written description requirement, and obviousness for lack of motivation to combine... [read post]
7 Jul 2020, 9:15 am
Sandoz, Inc., Sandoz International GMBH, Sandoz GMBH, holding that Sandoz failed to prove that the asserted claims were invalid for obviousness-type double patenting (ODP), failure to meet the written description requirement, and obviousness for lack of motivation to combine the prior art references. [read post]
15 Feb 2019, 12:47 am
The judgment was handed down in an invalidation action brought by Sandoz International GmbH. [read post]
9 Feb 2019, 3:45 am
Bart van WezenbeekRelevant prior art may prove not to be useful as a starting point for an attack on inventive step if the prior art teaching is negated by later studies before the effective date of the patent claims. [read post]
11 Sep 2018, 7:05 am
Sandoz, Inc., 544 F.3d1341, 1352 (Fed. [read post]
8 Feb 2017, 3:09 am
Anticipation: Grunenthal GmbH v. [read post]
16 Jan 2017, 5:44 pm
Anticipation: Grunenthal GmbH v. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
14 Nov 2016, 9:16 am
Petitions for Writ of Certiorari Denied or Dismissed: Anticipation: Grunenthal GmbH v. [read post]
13 Oct 2016, 6:50 am
Anticipation: Grunenthal GmbH v. [read post]
28 Sep 2016, 8:39 am
Acorda Therapeutics, et al., No. 16-360 Anticipation: Grunenthal GmbH v. [read post]
27 Sep 2016, 9:10 am
Panellists from Pfizer, Sandoz GmbH and Taiwan's National Yunlin University debated the global regulatory, substitution and interchangeability issues affecting biosimilars, before giving an overview of relevant patent litigation strategies. [read post]
22 Sep 2016, 5:32 pm
Vanessa reports:"In the second Pharma session on Monday, Moderator Dominic Adair (Bristows, UK) and panellists Fritz Reiter, (Regulatory CMC Team Leader, Sandoz GmbH, AT), Prof. [read post]
20 Sep 2016, 1:03 am
Moderator Dominic Adair (Partner, Bristows (UK)) led his panellists Fritz Reiter (Regulatory CMC Team Leader, Sandoz GmbH (AT)), Prof. [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation: Grunenthal GmbH v. [read post]
19 May 2016, 8:56 pm
• Defendants: Sandoz Inc.; Sandoz International GmbH; Sandoz GmbH; Lek Pharmaceuticals, d.d. [read post]
13 Dec 2015, 4:01 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 75 [week ending on Sunday 6 December] – BHG on blocking injunctions | IP in Universities | Sweden on blocking injunctions | Canadian musings on patents | US Senate and trade secret reform | Chinese IP Courts | G1/14 referral and Article 108 EPC | PACE procedure (Procedure for Accelerated Conduct of Examination) ant the EPO | Greekat and trade mark partenalism | EPO Boards of Appeal tell AC: we were… [read post]
